RAGE and HMGB1 Expression in Orbital Tissue Microenvironment in Graves’ Ophthalmopathy

Graves’ ophthalmopathy (GO) is a chronic autoimmune inflammatory disorder involving orbital tissues. A receptor for advanced glycation end products (RAGE) and its ligand high mobility group box 1 (HMGB1) protein trigger inflammation and cell proliferation and are involved in the pathogenesis of vari...

Full description

Saved in:
Bibliographic Details
Main Authors: Dominika Łacheta, Krzysztof B. Poślednik, Katarzyna Czerwaty, Nils Ludwig, Marta Molińska-Glura, Ireneusz Kantor, Anna Jabłońska-Pawlak, Piotr Miśkiewicz, Alicja Głuszko, Zygmunt Stopa, Jacek Brzost, Mirosław J. Szczepański
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2021/8891324
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849690045469949952
author Dominika Łacheta
Krzysztof B. Poślednik
Katarzyna Czerwaty
Nils Ludwig
Marta Molińska-Glura
Ireneusz Kantor
Anna Jabłońska-Pawlak
Piotr Miśkiewicz
Alicja Głuszko
Zygmunt Stopa
Jacek Brzost
Mirosław J. Szczepański
author_facet Dominika Łacheta
Krzysztof B. Poślednik
Katarzyna Czerwaty
Nils Ludwig
Marta Molińska-Glura
Ireneusz Kantor
Anna Jabłońska-Pawlak
Piotr Miśkiewicz
Alicja Głuszko
Zygmunt Stopa
Jacek Brzost
Mirosław J. Szczepański
author_sort Dominika Łacheta
collection DOAJ
description Graves’ ophthalmopathy (GO) is a chronic autoimmune inflammatory disorder involving orbital tissues. A receptor for advanced glycation end products (RAGE) and its ligand high mobility group box 1 (HMGB1) protein trigger inflammation and cell proliferation and are involved in the pathogenesis of various chronic inflammatory diseases. This study was aimed to evaluate RAGE and HMGB1 expression in GO to determine its potential clinical significance. To the best of our knowledge, this is the first study showing RAGE and HMGB1 expression in orbital tissue using immunohistochemistry. Sections of orbital adipose tissue obtained from patients diagnosed with GO (23 patients; 36 orbits) and normal controls (NC) (15 patients; 15 orbits) were analyzed by immunohistochemistry for RAGE and HMGB1 expression. Expression profiles were then correlated with clinical data of the study group. RAGE and HMGB1 expression were elevated in GO patients in comparison with NC (p=0.001 and p=0.02, respectively). We observed a correlation between RAGE expression and occurrence of dysthyroid optic neuropathy (DON) (p=0.05) and levels of TSH Receptor Antibodies (TRAb) (p=0.01). Overexpression of RAGE and HMGB1 might be associated with GO pathogenesis. In addition, RAGE and HMGB1 proteins may be considered as promising therapeutic targets, but this requires further research.
format Article
id doaj-art-ec5de3fc9dfc4e09a4fa3fd31f3ef390
institution DOAJ
issn 0962-9351
1466-1861
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-ec5de3fc9dfc4e09a4fa3fd31f3ef3902025-08-20T03:21:26ZengWileyMediators of Inflammation0962-93511466-18612021-01-01202110.1155/2021/88913248891324RAGE and HMGB1 Expression in Orbital Tissue Microenvironment in Graves’ OphthalmopathyDominika Łacheta0Krzysztof B. Poślednik1Katarzyna Czerwaty2Nils Ludwig3Marta Molińska-Glura4Ireneusz Kantor5Anna Jabłońska-Pawlak6Piotr Miśkiewicz7Alicja Głuszko8Zygmunt Stopa9Jacek Brzost10Mirosław J. Szczepański11Department of Biochemistry, Medical University of Warsaw, 02-097 Warsaw, PolandDepartment of Otolaryngology, Medical Centre for Postgraduate Education, 03-242 Warsaw, PolandDepartment of Otolaryngology, Medical Centre for Postgraduate Education, 03-242 Warsaw, PolandDepartment of Oral and Maxillofacial Surgery, University Hospital Regensburg, 93053 Regensburg, GermanyDepartment of Forest Technology of Poznan University of Life Sciences, 60-624 Poznan, PolandDepartment of Otolaryngology, Medical Centre for Postgraduate Education, 03-242 Warsaw, PolandDepartment of Ophthalmology, Medical University of Warsaw, 02-097 Warsaw, PolandDepartment of Internal Medicine and Endocrinology, Medical University of Warsaw, 02-097 Warsaw, PolandDepartment of Biochemistry, Medical University of Warsaw, 02-097 Warsaw, PolandDepartment of Maxillofacial Surgery, Medical University of Warsaw, 02-097 Warsaw, PolandDepartment of Otolaryngology, The Children’s Memorial Health Institute, 04-730 Warsaw, PolandDepartment of Biochemistry, Medical University of Warsaw, 02-097 Warsaw, PolandGraves’ ophthalmopathy (GO) is a chronic autoimmune inflammatory disorder involving orbital tissues. A receptor for advanced glycation end products (RAGE) and its ligand high mobility group box 1 (HMGB1) protein trigger inflammation and cell proliferation and are involved in the pathogenesis of various chronic inflammatory diseases. This study was aimed to evaluate RAGE and HMGB1 expression in GO to determine its potential clinical significance. To the best of our knowledge, this is the first study showing RAGE and HMGB1 expression in orbital tissue using immunohistochemistry. Sections of orbital adipose tissue obtained from patients diagnosed with GO (23 patients; 36 orbits) and normal controls (NC) (15 patients; 15 orbits) were analyzed by immunohistochemistry for RAGE and HMGB1 expression. Expression profiles were then correlated with clinical data of the study group. RAGE and HMGB1 expression were elevated in GO patients in comparison with NC (p=0.001 and p=0.02, respectively). We observed a correlation between RAGE expression and occurrence of dysthyroid optic neuropathy (DON) (p=0.05) and levels of TSH Receptor Antibodies (TRAb) (p=0.01). Overexpression of RAGE and HMGB1 might be associated with GO pathogenesis. In addition, RAGE and HMGB1 proteins may be considered as promising therapeutic targets, but this requires further research.http://dx.doi.org/10.1155/2021/8891324
spellingShingle Dominika Łacheta
Krzysztof B. Poślednik
Katarzyna Czerwaty
Nils Ludwig
Marta Molińska-Glura
Ireneusz Kantor
Anna Jabłońska-Pawlak
Piotr Miśkiewicz
Alicja Głuszko
Zygmunt Stopa
Jacek Brzost
Mirosław J. Szczepański
RAGE and HMGB1 Expression in Orbital Tissue Microenvironment in Graves’ Ophthalmopathy
Mediators of Inflammation
title RAGE and HMGB1 Expression in Orbital Tissue Microenvironment in Graves’ Ophthalmopathy
title_full RAGE and HMGB1 Expression in Orbital Tissue Microenvironment in Graves’ Ophthalmopathy
title_fullStr RAGE and HMGB1 Expression in Orbital Tissue Microenvironment in Graves’ Ophthalmopathy
title_full_unstemmed RAGE and HMGB1 Expression in Orbital Tissue Microenvironment in Graves’ Ophthalmopathy
title_short RAGE and HMGB1 Expression in Orbital Tissue Microenvironment in Graves’ Ophthalmopathy
title_sort rage and hmgb1 expression in orbital tissue microenvironment in graves ophthalmopathy
url http://dx.doi.org/10.1155/2021/8891324
work_keys_str_mv AT dominikałacheta rageandhmgb1expressioninorbitaltissuemicroenvironmentingravesophthalmopathy
AT krzysztofbposlednik rageandhmgb1expressioninorbitaltissuemicroenvironmentingravesophthalmopathy
AT katarzynaczerwaty rageandhmgb1expressioninorbitaltissuemicroenvironmentingravesophthalmopathy
AT nilsludwig rageandhmgb1expressioninorbitaltissuemicroenvironmentingravesophthalmopathy
AT martamolinskaglura rageandhmgb1expressioninorbitaltissuemicroenvironmentingravesophthalmopathy
AT ireneuszkantor rageandhmgb1expressioninorbitaltissuemicroenvironmentingravesophthalmopathy
AT annajabłonskapawlak rageandhmgb1expressioninorbitaltissuemicroenvironmentingravesophthalmopathy
AT piotrmiskiewicz rageandhmgb1expressioninorbitaltissuemicroenvironmentingravesophthalmopathy
AT alicjagłuszko rageandhmgb1expressioninorbitaltissuemicroenvironmentingravesophthalmopathy
AT zygmuntstopa rageandhmgb1expressioninorbitaltissuemicroenvironmentingravesophthalmopathy
AT jacekbrzost rageandhmgb1expressioninorbitaltissuemicroenvironmentingravesophthalmopathy
AT mirosławjszczepanski rageandhmgb1expressioninorbitaltissuemicroenvironmentingravesophthalmopathy